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The development of an in vitro method to measure the
sensitivity of tumour cells to cytotoxic drugs, so that the
most effective drugs may be chosen for treatment is a major
goal in cancer chemotherapy. A number of authors have
reported that colony-forming assays appeared to be the most
reliable dose-dependent index of cell lethality in vitro, and
that other methods, such as dye exclusion, were inadequate
to measure drug-induced cytotoxicity (Bhuyan et al., 1976;
Roper & Drewinko, 1976; Rupniak et al., 1983). More
recently, however, an assay based on dye-exclusion, the
differential staining cytotoxicity (DiSC) assay, has been
developed which overcomes many of the theoretical and
technical pitfalls inherent in traditional dye-exclusion
methods (Bird et al., 1985, 1986; Weisenthal et al., 1983a,
1984). The biological and clinical validity of this assay have
been demonstrated for a number of primary solid and
haematological tumour types (Bird et al., 1985, 1986;
Weisenthal et al., 1984), and the theoretical basis of the
assay has recently been carefully assessed (Weisenthal &
Lippman, 1985). We now report the results of comparing the
DiSC assay with a colony-forming assay using 4 classes of
cytotoxic drugs in 3 human haematological tumour cell lines.
K562 human erythroleukaemia cells were obtained from
Immune Chemistry, South West Regional Blood Transfusion
Centre, Bristol. HL60 human promyelocytic leukaemia cells
were a gift from Dr C. Hills of the Institute of Cancer
Research, Sutton. MOLT-4 human T-lymphoblastic
leukaemia cells were from Flow Laboratories, Irvine,
Scotland. All three cell lines were maintained in liquid
culture with RPMI 1640 medium containing 10% foetal calf
serum (RPMI-FCS).
Drug source, storage conditions and manipulations have
been reported previously (Bird et al., 1986). Drugs were
incubated for I h at 37°C with cells harvested in logarithmic-
phase growth.
The DiSC assay was performed (in Bath) as previously
described (Bird et al., 1985) but using 103-2 x104 cells in
1 ml of RPMI-FCS. Briefly, after drug exposure, cells were
incubated at 37°C for 4 days. Following this, the cells were
stained with nigrosin-fast green containing a known number
of fixed duck red blood cells (DRBC) and cytocentrifuged
onto collagen-coated slides. The slides were fixed and
counterstained with a Romanowsky stain. The ratio of live
cells over DRBC was determined for each slide, and the
ratio in drug-treated samples expressed as a percentage of
that in the control.
For the colony-forming assay (performed in Bristol), the
same number of cells were plated in a 1 ml upper layer of
0.3% agar in RPMI-FCS over a base layer of 0.5% agar in
the same medium. Colonies were counted at 10-14 days.
Cloning efficiencies were approximately 85%, 4% and 5%
for the K562, HL60 and MOLT-4 cell lines respectively.
Dose response curves were constructed from 2 or 3 experi-
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ments. Three plates were set up for each drug concentration
within each experiment. The dose-response curves were
compared at the end of the study. The cell lines for the two
assays were obtained from the same source but grown
separately at the two study centres.
Figures 1-3 show the effect of a 1 h drug-exposure of each
of the 4 drugs studied on K562, HL60 and MOLT-4 cells
respectively. Both the DiSC assay and the colony-forming
assay showed a clear dose response relationship for all drugs
tested. For the non-phase specific drugs vincristine, 4-hydro-
peroxycyclophosphamide (4-HC) and adriamycin, the DiSC
assay gave either an equal or a lower estimate of cell kill,
with drug concentrations at the LD50 between 0.8 and 12
times higher than for the colony-forming assay. In contrast,
the phase-specific drug cytarabine showed higher cell kill in
the DiSC assay and drug concentrations at the LD50 4-10
times lower.
A number of investigators have shown little or no cell kill
with traditional dye-exclusion assays at drug concentrations
giving a clear dose-response relationship with the colony-
forming assay (Roper & Drewinko, 1976; Rupniak et al.,
1983). Weisenthal et al. (1983b) suggested that this failure of
dye-exclusion assays to accurately reflect the reproductive
capacity of tumour cell populations was probably due to a
number of pitfalls associated with earlier assays of this type.
The DiSC assay has been developed to overcome these
pitfalls, and includes significant modifications from
traditional dye-exclusion methods which give it a far better
theoretical basis (Weisenthal & Lippman, 1985).
In this study we have tested the ability of the DiSC assay
to assess cytotoxicity, and to determine whether the index of
early loss of viability correlates with the loss of reproductive
potential. A 1 h drug exposure was used to ensure that
cytotoxic rather than cytostatic effects were measured. One
drug from each of four different classes of anti-tumour
agents was employed including both cell cycle phase specific
and non-specific drugs. The results obtained indicate that the
cytotoxicities of drugs with widely differing mechanisms of
action are able to be assessed with the DiSC assay, in
contrast to traditional dye-exclusion assays. The DiSC assay
therefore represents a considerable improvement over such
assays.
We have shown the colony-forming assay to be generally
more sensitive to the drugs tested that are not strictly phase
specific, whilst with cytarabine, the DiSC assay has shown a
greater sensitivity. This latter result, together with a similar
finding of Weisenthal and colleagues (1983b) testing metho-
trexate, suggests that the DiSC assay may be more sensitive
for phase specific drugs. The reasons for this are unclear, but
may indicate that after manipulation, cells re-enter the cell
cycle more rapidly in liquid culture than in the more
stressful agarose environment.
The results of this study suggest that these two assay
methodologies are not strictly comparable. Thus the drug
concentrations used to predict for patient response with the
two assays could be expected to be different by as much as
one order ofmagnitude or more.
Ultimately the most valid comparison of different chemo-
(-. The Macmillan Press Ltd., 1987 Br. J. Cancer (1987), 55, 429-431K562
60
40
-, 4-HC concentration (p.g ml- )
-A
0.5 1 2 5 10 20
Ara C concentration (j±g ml-') Adr concentration (ng ml-')
Figure 1 Comparison of the DiSC assay (A A) with the colony-forming assay (A---A) for K562 cells. Results are the
mean +s.d. of the three separate experiments 4-HC, 4-hydroperoxycyclophosphamide; VC, vincristine; Ara C, cytarabine; Adr,
adriamycin.
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Figure 2 Comparison of the DiSC assay (A A) with the colony-forming assay (0- --0) for HL60 cells. Results are the
mean +s.d. of 2 (colony-forming assay) or 3 (DiSC assay) separate experiments. Abbreviations as for Figure 1.
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Figure 3 Comparison of the DiSC assay (A A) with the colony-forming assay (@---@) for MOLT-4 cells. Results are the
mean +s.d. of 2 (colony-forming assay) or 3 (DiSC assay) separate experiments. Abbreviations as for Figure 1.
sensitivity assays is how well they predict clinical responsive-
ness. Such direct comparison studies have not yet been done
for the DiSC and colony-forming assays. However, retro-
spective correlations of clinical response for the two assays
show similar accuracy (Weisenthal & Lippman, 1985),
indicating that neither method is superior to the other.
The DiSC assay is a relatively simple in vitro drug
sensitivity assay that is capable of being easily performed by
hospital haematology staff, and does not use radioactive
materials or complicated procedures. To this end, we believe
that the DiSC assay has much to offer as a routine drug-
sensitivity test, and that its role in the prediction of tumour
response to chemotherapy should be further evaluated.
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